Literature DB >> 517521

Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: effects on knowledge and mood.

P T Rowley, L Fisher, M Lipkin.   

Abstract

To evaluate the effects of genetic screening and counseling in a population unselected for interest, adults in a health maintenance organization (HMO) were screened for beta-thalassemia trait as part of health care or multiphasic screening. Counseling was provided by either a trained physician or a videotape containing the same information, followed by an opportunity to question a trained physician. Knowledge of thalassemia, knowledge of genetics, and mood were assessed by standardized questionnaires and by interview immediately before and after counseling. Compared to controls, trait subjects demonstrated significant learning about thalassemia (P less than .001) and about genetics (P less than .001) and recorded significant mood changes, namely, surprise (startle) (P less than .05), increased alertness (decreased deactivation) (P less than .05), and decreased skepticism (P less than .01). Screening and genetic counseling for beta-thalassemia trait conducted as part of multiphasic screening of the population of a HMO, essentially and unselected population, can result in significant overall learning with acceptable effects on mood.

Entities:  

Mesh:

Year:  1979        PMID: 517521      PMCID: PMC1686028     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  41 in total

1.  Tay-Sachs screening: social and psychological impact.

Authors:  B Childs; L Gordis; M M Kaback; H H Kazazian
Journal:  Am J Hum Genet       Date:  1976-11       Impact factor: 11.025

2.  PSYCHODYNAMICS OF EARLY HEREDITARY DEATHS. ROLE OF THE MEDICAL GENETICS COUNSELOR.

Authors:  H T LYNCH; T P KRUSH; A J KRUSH; R L TIPS
Journal:  Am J Dis Child       Date:  1964-12

3.  THE "WHOLE FAMILY" CONCEPT IN CLINICAL GENETICS.

Authors:  R L TIPS; G S SMITH; H T LYNCH; C W MCNUTT
Journal:  Am J Dis Child       Date:  1964-01

4.  Reciprocal relationship of hemoglobins A2 and F in beta chain thalassemias, a key to the genetic control of hemoglobin F.

Authors:  W W ZUELZER; A R ROBINSON; C R BOOKER
Journal:  Blood       Date:  1961-04       Impact factor: 22.113

5.  Psychiatric aspects of genetic counseling.

Authors:  F J KALLMANN
Journal:  Am J Hum Genet       Date:  1956-06       Impact factor: 11.025

6.  Variables in the outcome of genetic counseling.

Authors:  R M Antley
Journal:  Soc Biol       Date:  1976 SUMMER

7.  Tay-Sachs disease and carrier screening programs: psychosocial aspects.

Authors:  G Schneiderman; J A Lowden; Q Rae-grant
Journal:  Can J Public Health       Date:  1977 Jan-Feb

Review 8.  The diagnosis of beta-thalassemia trait: a review.

Authors:  P T Rowley
Journal:  Am J Hematol       Date:  1976       Impact factor: 10.047

9.  The personal impact of Tay-Sachs carrier screening.

Authors:  B Childs
Journal:  Prog Clin Biol Res       Date:  1977

10.  Public health aspects of Tay-Sachs screening.

Authors:  I M Rosenstock
Journal:  Prog Clin Biol Res       Date:  1977
View more
  8 in total

1.  Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: comparison of three counseling methods.

Authors:  P T Rowley; M Lipkin; L Fisher
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

2.  Genetic counseling for beta-thalassemia trait following health screening in a health maintenance organization: comparison of programmed and conventional counseling.

Authors:  L Fisher; P T Rowley; M Lipkin
Journal:  Am J Hum Genet       Date:  1981-11       Impact factor: 11.025

3.  Sickle cell trait counseling-evaluation of counselors and counselees.

Authors:  C F Whitten; J F Thomas; E N Nishiura
Journal:  Am J Hum Genet       Date:  1981-09       Impact factor: 11.025

4.  Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in Sardinia.

Authors:  A Cao; M Furbetta; R Galanello; M A Melis; A Angius; A Ximenes; C Rosatelli; R Ruggeri; M Addis; T Tuveri; A M Falchi; E Paglietti; M T Scalas
Journal:  Am J Hum Genet       Date:  1981-07       Impact factor: 11.025

5.  Comparing knowledge of beta-thalassemia in samples of Italians, Italian-Americans, and non-Italian-Americans.

Authors:  Christina Armeli; Steven J Robbins; Deborah Eunpu
Journal:  J Genet Couns       Date:  2005-10       Impact factor: 2.537

6.  Beta-thalassemia disease prevention: genetic medicine applied.

Authors:  C R Scriver; M Bardanis; L Cartier; C L Clow; G A Lancaster; J T Ostrowsky
Journal:  Am J Hum Genet       Date:  1984-09       Impact factor: 11.025

7.  Prenatal screening for hemoglobinopathies. I. A prospective regional trial.

Authors:  P T Rowley; S Loader; C J Sutera; M Walden; A Kozyra
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

Review 8.  Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.

Authors:  Norita Hussein; Stephen F Weng; Joe Kai; Jos Kleijnen; Nadeem Qureshi
Journal:  Cochrane Database Syst Rev       Date:  2018-03-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.